Skip to main content
Fig. 7 | Journal of Ovarian Research

Fig. 7

From: FPR2 participates in epithelial ovarian cancer (EOC) progression through RhoA-mediated M2 macrophage polarization

Fig. 7

(A) Xenografts were inoculated subcutaneously with SKOV3 cell lines (NC group) and SKOV3−shFPR2 cell lines (KD group). (B) Tumour volumes showed a significant upwards trend in the NC group compared to the FPR2 knockout group. (B) The average tumour weight on Day 47 after subcutaneous inoculation was significantly heavier in the FPR2 knockout group than in the NC group (**P < 0.01)

Back to article page

Journal of Ovarian Research

ISSN: 1757-2215

Contact us